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Background: Prolonged stress leads over time to allostatic load on the body and is likely to exacerbate a disease
process. Long-term of stress exposure is one of a risk factor for metabolism-related diseases such as obesity and
type 2 diabetes. However, the relationship between chronic stress and non-alcoholic fatty liver disease (NAFLD)
remain unknown.
Methods: To address the hypothesis that chronic stress associate to NAFLD development, we subjected C57bl/6
mice to electric foot shock and restraint stress for 12 weeks to set up chronic stress model. Then the serum and
hepatic triglyceride (TG), total cholesterol (TC) were measured. Hepatic HE and Oil red O staining were used to
specify the state of the NAFLD. To investigate whether inflammation takes part in the stress-induced NAFLD
process, related visceral fat, serum and hepatic inflammatory factors were measured.
Results: We observed that chronic stress led to an overall increase of hepatic triglyceride and cholesterol while
decreasing body weight and visceral fat mass. Microvesicular steatosis, lobular inflammation and ballooning
degeneration were seen in stress liver section. This effect was correlated with elevated hepatic and serum
inflammatory factors. Although the amount of visceral fat was decreased in stress group, various adipocytokines
were elevated.
Conclusions: We showed that chronic stress is associated to NAFLD and chronic inflammation in visceral fat,
though food intake and visceral fat mass were decreased. These results may contribute to better understanding of
the mechanism from steatosis to steatohepatitis, and propose a novel insight into the prevention and treatment of
NAFLD.
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Non-alcoholic fatty liver disease (NAFLD), characterized
by the accumulation of large droplets of triglyceride within
hepatocytes in the absence of chronic alcohol consump-
tion, is a leading cause of hepatic dysfunction. NAFLD
represents a wide spectrum of diseases, ranging from
simple steatosis, through steatosis with inflammation
(non-alcoholic steatohepatitis, NASH) to cirrhosis. Al-
though simple hepatic steatosis is a slowly-developed and
asymptomatic disease, the next stage NASH is more likely
to cause progressive cirrhosis, hepatocellular carcinoma* Correspondence: qushencn@hotmail.com; cljiang@vip.163.com
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unless otherwise stated.and increased mortality [1]. The prevalence of NAFLD
has increased dramatically over the last three decades, at
nearly 15-30% in the general population in western coun-
tries and approximate 15% in big cities of China [2,3].
Despite its high prevalence, factors leading to progression
from NAFLD to NASH remain obscure and there is no
pharmacological agent approved for the treatment of
NAFLD [4].
One major concern is chronic inflammation plays a
key role in the pathogenesis of NAFLD [5]. IL-6 and
TNF-α, two important inflammatory cytokines, pro-
foundly increased in human patients with NAFLD [6].
Other studies also found a clear correlation between
liver IL-6 and TNF-α expression level and NAFLD disease
severity [7,8]. The absence of either IL-6 or TNF receptor
1 (TNFR1), decreased high-fat diet induced liver lipidThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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duced infiltration with macrophages and neutrophils [9].
Stress systems play a crucial role in maintaining hom-
oeostasis to adapt to the environmental demands im-
posed by change [10]. However, strong and long-lasting
stress stimuli could disturbances in the internal environ-
ment, thereby increasing the risk of various health prob-
lems. In modern society, which is characterized by a rapid
pace of life, individuals are continuously confronted with
an increasing number of stressful stimuli, such as emo-
tional stimuli and social stress. It had been validated by
clinical trials that chronic stress from work and low quality
of life may be the risk factor of obesity and metabolism
syndrome [11,12].
Since chronic stress could lead to systematic inflam-
mation [13], we assume that chronic stress may take part
in the process of NAFLD. Yet the relationship between
chronic stress and NAFLD has not been clarified. Thus,
the overall objective of this study was to demonstrate
whether chronic stress could lead to NAFLD.
Methods
Experimental animals
Twenty female C57bl/6 mice (8 weeks of age; Sino-British
SIPPR/BK Lad Animal Ltd, Shanghai, China) were allowed
to acclimate to the environment for 7 days before the
experiments began. Then they were randomly assigned
to the control or stress group (n = 10, respectively).
Control mice were left undistributed, while stress mice
were suffered from chronic stress for 12 weeks. The
detail process was described in next paragraph. Food
intake was measured by weighing the pellets once per
week. All animals were maintained on a 12-hour light/
12-hour dark cycle with food and water freely available.
The temperature of the colony room was maintained at
22°C to 23°C. Animal protocols were approved by the
Animal Care and Use Committee of the Second Military
Medical University.
Stress protocol
During the 12 weeks, the mice in stress group were
administered electric foot shock and restraint stress
every day [14,15]. At 10:00 am, each mouse was placed
in a box with a floor composed of stainless grids, and a
scrambled electric shock was delivered through the floor
grids by a PST-001 AC stimulator (StarMedical, Tokyo,
Japan). An interval timer was connected to the stimulator
to allow shocks for 7.5-second periods every 2 minutes,
the intensity of which was 25v. At 7:00 pm, stressed mice
were individually subjected to 2 h of restraint stress as
described previously [16]. In brief, restraint stress was
applied using a 50-mL conical centrifuge tube with
multiple punctures that allowed for a close fit to mice.
Control mice were kept isolated from stressed animalsand maintained with access to food or water during the
same period of stress process to avoid any acoustic or
olfactory communication between the groups.
Experimental procedures
After 12 weeks, all mice were fasted overnight then anes-
thetized using isoflurane. Blood was collected by orbital
puncture, followed by sacrifice via cervical dislocation.
Then the whole liver and intra-abdominal adipose were
removed and weighed. For histology, a small part of liver
and visceral fat were immediately fixed in 10% formalin,
and processed for paraffin embedding. The rest of the liver
was stored at −80°C for biochemical analysis.
Determination of fat cell size
For these studies in fat tissue derived from mice eutha-
nized at 12 week, two sections apart were selected, and
the adipocyte cell size in three random fields in each
section was determined. Because the cells were not uni-
formly round, the shortest length between the opposite
cell membranes was measured routinely. For each cell,
the inter-membrane distance was measured by including
the central point in the cell in these planar images,
where the lengths were measured in all of the complete
cells within the field using Image J. Results were collated
for each animal grouping.
Hematoxylin-Eosin (HE) and oil red o staining of liver
sections
Following fixation of the livers with10% formalin/phos-
phate-buffered saline, livers were sliced and stained with
HE for histological examination. Liver steatosis was
graded semi-quantitatively based on the percentage of
hepatocytes according to the following criteria: grade 0,
no hepatocytes involved; grade 1, 1% to 25% of hepa-
tocytes involved; grade 2, 26% to 50% of hepatocytes
involved; grade 3, 51% to 75% of hepatocytes involved;
and grade 4, 76% to 100% of hepatocytes involved.
Hepatic lipid content was also determined by staining
with Oil Red O (Sigma). The percentage of the area
occupied by oil red O-stained lipid droplets was calcu-
lated using Image J, averaging 3–5 separate, randomly
selected 40× fields.
Serum biochemical analysis
The serum triglyceride (TG), total cholesterol (TC), free
fatty acid (FFA), alanine aminotransferase (ALT), and aspar-
tate aminotransferase (AST) were measured by an auto-
matic biochemistry analyzer(Hitachi 7170, Tokyo, Japan).
Measurement of hepatic lipids
Livers were homogenized at 4°C in lysis buffer containing
50 mmol/L Tris (pH8.0), 150 mmol/L NaCl, 1% Triton
X-100, and 0.5% sodium deoxycholate. Lipids from the
Figure 1 Effects of stress on weight gain and food intake. C57 BL/6 mice were received stress procedure for 12 weeks. (A) Changes in body
weight. White squares = control (n = 10), Black squares = stress (n = 10). (B) Food intake during the course of the stress stimulating. Error bars
represent standard error (SE). *P < 0.05, **P < 0.01 versus control mice.
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form/methanol method (2:1), evaporated, and dissolved
in 2-propanol. Amounts of TC and TG were measured
by an automatic biochemistry analyzer (Hitachi 7170,
Tokyo, Japan).
Measurement of cytokines
Serum, adipose and liver samples were profiled with The
Bio-Plex mouse Cytokine 17-Plex panel was used with theFigure 2 Characterization of intra-abdominal adipose tissue and seru
tissues from the control and stress mice received 12 weeks stress protocol.
intra-abdominal adipose tissue of stress mice received 12 weeks stress prot
calculated by Image J (C) Serum FFA content. Error bars represent standardBio-Plex Suspension Array System (Bio-Rad, Hercules,
CA, USA) to profile expression of 7 inflammatory media-
tors, including IL-6, TNF-α, IL-1β, IL-18, MCP-1, MIP-2
and PAI-1. The assay was performed according to the
manufacturer’s instructions.
Data analysis
The data are presented as means ± SEM. Group means
were compared utilizing a paired Student’s t-test or them FFA of chronic stress mice. (A) Weight of intra-abdominal adipose
Error bars represent standard error (SE) (n = 10). (B) HE staining of
ocol. Magnification, ×100. Scale bars: 50 μm. Average cell sizes were
error (SE). **P < 0.01, ***P < 0.001 versus control mice.
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lysis of food intake and body weight was performed by
ANOVA for repeated measures as appropriate. P < 0.05
was considered statistically significant.
Results
Chronic stress leads to decreased food intake and body
weight gain
To investigate whether chronic stress is linked to NAFLD
progression, we made a 12 weeks stress protocol for
C57BL/6 mice in order to lead to chronic stress status.
During 12 weeks, the food intake and body weight of
control group were steadily increased, while stress
group didn’t show increased food intake and body
weight gain. At the end of the time, both body weight
and food intake gain were significantly lower in stress
group (t (18) = 6.643, p <0.0001; t (18) = 3.882, p = 0.001)
(Figure 1A, B).
Chronic stress decreases visceral fat mass but increases
inflammatory cytokines secretion
The amount of visceral adipose and adipocytokines is
known to have a closely relationship with the develop-
ment of NAFLD. Thus, we firstly measured visceral fat
mass and serum FFA. The stress mice exhibited re-
markable reduction of visceral mass compared to con-
trol ones (t (18) = 4.97, p = 0.0001) (Figure 2A), and HE
staining showed that adipocytes of stress group were
significantly smaller than control ones (t (8) = 3.055,Figure 3 Effects of chronic stress on the release of selected adipokine
IL: interleukin, TNF-α: tumor necrosis factor-alpha, MCP-1: monocyte chemo
PAI-1: plasminogen activator inhibitor-1. Error bars represent standard errorp = 0.0157) (Figure 2B). Consistence with these results,
Serum FFA was significantly elevated in stress group
(t (18) = 2.846, p = 0.0107) (Figure 2C). These data indi-
cate that chronic stress could lead to decreased amount
of visceral fat and increased lipolysis.
Since adipokine signaling is thought to be the means
of NAFLD [17,18], we thought to determine how these
molecules differed with chronic stress pattern. Adipose
adipokine levels were examined after 12 weeks stress
protocol. The results turned out that although the amount
of visceral adipose was decreased, a variety of inflam-
matory factors of visceral adipose were elevated in
stress mice. IL-6 and IL-1β were significantly increased
(t (18) = 2.800, p = 0.011; t (18) = 2.712, p = 0.014), while
others like TNF-α, IL-18 were not changed (t (18) = 0.670,
p = 0.508; t (18) = 0.531, p = 0.600). Combined with
cytokines, a lot of chemokines such as macrophage
inflammatory protein 2 (MIP-2), monocyte chemo-
attractant protein-1(MCP-1) and PAI-1, related to inflam-
matory cells gathering were elevated too (t (18) = 2.236,
p = 0.049; t (18) = 2.556, p = 0.029; t (18) = 2.756; p = 0.004)
(Figure 3).
Chronic stress induces steatosis
Although stress group had less food intake and weight
gain, their hepatic index (HI, the ratio of liver weight to
body weight × 100), which usually reflect the fatty liver
status, was significantly elevated (t (18) = 0.588, p < 0.001)
(Figure 4A). To ensure this phenomenon, Serum lipids and cytokines by visceral adipose tissue from C57 BL/6 mice.
attractant protein-1, MIP-2: macrophage inflammatory protein 2,
(SE). *P < 0.05 versus control mice.
Figure 4 Chronic stress induces hepatic TG and TC accumulation. After mice were anesthetized, whole liver were removed and weighed.
Hepatic lipids were extracted, and TG, TC concentrations were measured. (A) Hepatic index = Liver weight (mg)/body weight (g). (B) The
levels of serum TC and TG content are represented in bar chart, respectively. (C) Liver TG and TC concentrations in stress group and control
group. (D) Representative slides show hematoxylin and eosin (H&E)-stained and Oil red O-stained liver sections from control mice or stress
mice for 12 weeks. The percentage of the area occupied by oil red O–stained lipid droplets was calculated using Image J, averaging 3–5
separate, randomly selected 40× fields. HE sections show chronic stress causing hepatocytes ballooning (yellow arrows). In addition, there are
foci of inflammatory cell infiltration and lipid deposits (white arrows) Original magnification, ×100. Scale bars: 50 μm. Error bars represent
standard error (SE). *P < 0.05, ***P < 0.001 versus control mice.
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were evaluated. Serum TC and TG showed increasing
tendency but had no statistical significance (t (11) =
1.560, p = 0.147; t (11) = 1.650, p = 0.127) (Figure 4B).
Then we evaluated the liver TG and TC concentration
and Oil red O staining to certify whether stress cause
lipid deposition in liver. Quantitative analysis showed a
significant increase in hepatic TG and TC content
in stressed mice (t (18) = 2.770, p = 0.013; t (18) = 2.389,
p = 0.028) (Figure 4C), which was confirmed by histo-
logical staining using Oil red O (t (8) =3.093, p = 0.015)
(Figure 4D). Together, these data suggest that chronic
stress could induce liver steatosis independent of the
dietary factor.Stress not only leads to steatosis, but also NASH
The former results illustrated that stress could induce
liver steatosis and chronic inflammation state. We wanted
to further investigate whether the mice encountered stress
could develop to NASH. The results showed that stressed
mice developed exacerbated NASH compared to wild-
type mice as judged by increased levels of serum ALT and
AST (t (13) = 3.271, p = 0.006; t (11) = 2.735, p = 0.0194),
and NAFLD activity inflammation scores (t (18) = 2.742,
p = 0.0134; t (18) = 3.899, p = 0.001) (Figure 5).
To figure out which cytokines take part in NASH, we
detected the cytokines closely related to NASH in both
liver and serum. For IL-6 and TNF-α, stress mice had both
higher serum and liver levels than control ones (serum
Figure 5 The serum activities of two hepatic injury-associated enzymes, alanine aminotransferase (ALT), and aspartate aminotransferase
(AST), at the end of the treatment period. The NAFLD activity score is evaluated by New York NAFLD score system. *P < 0.05, **P < 0.01 versus
control mice.
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p = 0.0123; serum TNF-α: t (9) = 3.479, p = 0.007; liver
TNF-α: t (18) =3.023, p = 0.007). For IL-1β and MCP-1,
serum levels were higher in mice given chronic stress com-
pared with controls (t (18) = 3.365, p = 0.004; t (18) = 2.191,
p = 0.042) while liver levels didn’t change (t (18) = 1.784,
p = 0.091; t (18) =1.492, p = 0.153). For IL-18, the two
groups showed same level in serum and liver after the
stress treatment (t (18) = 1.334, p = 0.199; t (18) = 1.140,
p = 0.269) (Figure 6).Discussion
The key finding in the present study is that mice could
develop NASH only in intervention of chronic stress,
despite the reduction in food intake and visceral fat,
which always recognized as the risk factor of the meta-
bolic disorder [19]. Furthermore, chronic stress could
lead to chronic inflammatory state, including high con-
centration of inflammatory factors, such as TNF-α and
IL-6, both in the circulation and liver. While previous
studies mostly concentrated on the effect of chronic
stress on obesity or metabolic syndrome combined with
the high-fat diet [20], this is, to our knowledge, the first
study indicating that chronic stress is a contributingfactor of NAFLD, since the dietary factor and other
related factors could be excluded in this experiment.
In some clinical trials, the amount of visceral fat is
highly correlated with liver steatosis and steatohepatitis
[21-23]. Obese persons with excess visceral adipose
tissue are at higher risk for NAFLD components than
those whose fat is predominantly located in the subcuta-
neous part [24]. Furthermore, weight loss induced by
bariatric surgery is suggested to be responsible for the
benefits in liver function and steatosis [25]. However, we
noticed that, although stressed mice had less visceral fat
content, they still exhibited a significantly higher hepatic
TG and serum FFA level while the serum TC and TG
were unchanged. The volume of fat tissue depends on
its content of triglyceride. Therefore, we speculate that
increase FFA was caused by lipotropic action in visceral
adipose.
Apart from its ability of releasing and delivering FFA
into the portal vein, visceral fat could secrete a variety of
soluble factors which might be important sources to
promote steatosis [26]. Then we detected the inflam-
mation factors in visceral fat. The result showed that a
variety of inflammatory cytokines and chemokines, such
as IL-6, IL-1β, MIP-2 and MCP-1, elevated in the visceral
adipose of stressed group. MIP-2 is a potent chemotactic
Figure 6 Effects of chronic stress on the release of selected adipokines and cytokines by serum and liver from C57 BL/6 mice.
IL: interleukin, TNF-α: tumor necrosis factor-alpha, MCP-1: monocyte chemoattractant protein-1, PAI-1: plasminogen activator inhibitor-1. Error bars
represent standard error (SE). *P < 0.05 versus control mice.
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secreted from stimulated macrophages [27]. MCP-1is
secreted by a variety of cells as a response to several
inflammatory stimuli, and play an important role in the
stimulation of the inflammatory infiltrate. It could
enhance expression of adhesion molecules in monocytes
and promotion of pro-inflammatory cytokine synthesis
[28,29]. All of these chemokines have the ability to activate
and attract inflammatory cells, thus amplifying the inflam-
matory cascade. On the basis of these results, we infer that,chronic stress might induce steatosis through two ways: (1)
chronic stress promotes visceral adipose lipolysis, thus
increasing liver FFA input; (2) chronic stress lead to secre-
tion of inflammatory cytokines and chemokines in visceral
adipose tissue. However, the link between inflammatory
adipose tissue and steatosis need to be further illustrated.
Conclusions
In conclusion, this study provides a new insight into the
pathogenesis of NAFLD. Our findings demonstrate that
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factor of NAFLD, although stressed mice had less food
intake and weight gain. Furthermore, visceral adipose
and hepatic inflammation may be the crucial mechanism
of the stress-induced NAFLD, which need to be further
proved. Up to now, there is a common sense that
NAFLD is largely a hepatic manifestation of obesity
and metabolic syndrome. Therefore, these results may
remind us that, those who have normal weight and
hip-waist ratio but suffer long-term stress may also
have the chance to have NAFLD. To prevent NAFLD,
not only should we restrict the calorie properly, we
also should concentrate on stress management.
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